首页> 外国专利> METHODS AND COMPOSITIONS FOR INFUSING SELECTED POPULATIONS OF ALLOGENOUS Lymphocytes FOR TEMPORARY CANCER TREATMENT

METHODS AND COMPOSITIONS FOR INFUSING SELECTED POPULATIONS OF ALLOGENOUS Lymphocytes FOR TEMPORARY CANCER TREATMENT

机译:输注同种异体淋巴细胞的部分人群用于临时癌症治疗的方法和成分

摘要

The invention provides methods and compositions for administration of allogeneic lymphocytes as an an exogenous source of CD4+ T cell help for endogenous, tumor-reactive CD8+ T cells. Depletion of CD8+ T cells from the donor lymphocyte infusion reduces the risk of sustained engraftment and graft-versus-host disease. Removal of regulatory T cells from the infused population may augment the ability of non-regulatory T cells to provide help for endogenous effectors of anti-tumor immunity. Allogeneic T cell therapy is typically given in the context of allogeneic stem cell transplantation, in which the patient receives highly immunosuppressive conditioning followed by an infusion of a stem cell graft containing unselected populations of mature T cells. In the treatment described here, the graft is engineered to minimize the possibility of sustained donor cell engraftment, and the anti-tumor effector T cells derive from the host.
机译:本发明提供用于给予同种异体淋巴细胞作为内源性,肿瘤反应性CD8 + T细胞的CD4 + T细胞帮助的外源来源的方法和组合物。从供体淋巴细胞输注中耗尽CD8 + T细胞可降低持续移植和移植物抗宿主疾病的风险。从注入的群体中去除调节性T细胞可以增强非调节性T细胞为内源性抗肿瘤免疫效应子提供帮助的能力。同种异体T细胞疗法通常是在同种异体干细胞移植的背景下进行的,其中患者接受高度免疫抑制条件,然后输注含有未选择的成熟T细胞群体的干细胞移植物。在此处描述的治疗方法中,对移植物进行了工程设计,以最大程度地减少供体细胞持续移植的可能性,并且抗肿瘤效应T细胞来源于宿主。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号